76503 Dupilumab in prurigo nodularis: 3-months follow-up insights into GLOBOSPIN, a global observational study
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB167
DOI: 10.1016/j.jaad.2026.04.690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Firouzeh Niakosari und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Niakosari, F., Loo, W. J., Li, L., Nakajima, S., Wei, E. X., Hawley, K. B., Compagnoni, A., Zahn, J., & Bosman, K. (2026). 76503 Dupilumab in prurigo nodularis: 3-months follow-up insights into GLOBOSPIN, a global observational study. Journal of the American Academy of Dermatology, 95(1), AB167. https://doi.org/10.1016/j.jaad.2026.04.690
Vancouver
Niakosari F, Loo WJ, Li L, Nakajima S, Wei EX, Hawley KB, et al. 76503 Dupilumab in prurigo nodularis: 3-months follow-up insights into GLOBOSPIN, a global observational study. Journal of the American Academy of Dermatology. 2026;95(1):AB167. doi:10.1016/j.jaad.2026.04.690
BibTeX
@article{Niakosari2026,
author = {Niakosari, Firouzeh and Loo, Wei Jing and Li, Linfeng and Nakajima, Saeko and Wei, Erin X. and Hawley, Kristi B. and Compagnoni, Anna and Zahn, Joseph and Bosman, Kwinten},
title = {76503 Dupilumab in prurigo nodularis: 3-months follow-up insights into GLOBOSPIN, a global observational study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB167},
doi = {10.1016/j.jaad.2026.04.690}
}
EUVIMED